BFM News Profile picture
18 Nov, 5 tweets, 2 min read
1. The Women’s Tennis Association has doubted the authenticity of an email purportedly from Chinese tennis player Peng Shuai, which was published by Chinese state broadcaster CGTN.

Peng has not been heard from since alleging sexual assault by a retired senior Chinese politician.
2. The email, allegedly written by Peng, claimed that she is not missing or unsafe, and that the sexual assault allegation linked to her was not true.

“I have a hard time believing that Peng Shuai actually wrote the email we received,” WTA president Steve Simon said.
3. Simon also said CGTN’s statement only raises his concerns as to Peng's safety and whereabouts.

Peng wrote on Weibo earlier this month that she was forced into a sexual relationship with former Chinese Vice Premier Zhang Gaoli. The post has since been removed.
4. Simon however lauded Peng’s courage in making the post.

“She must be allowed to speak freely, without coercion or intimidation from any source.”

The WTA has called for independent and verifiable proof that she is safe, after numerous failed attempts to reach her directly.
5. Others have also doubted the email’s legitimacy, with many on social media pointing out that a typing cursor is visible in the screenshot of the email provided by CGTN.

The hashtag #WhereisPengShuai has also been trending on Twitter.

Screenshot: CGTN

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with BFM News

BFM News Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @NewsBFM

18 Nov
1. The Selangor Health Department has confirmed that Sungai Buloh Hospital’s ICU capacity has reached 96%, as of 8am.

This follows a tweet by a doctor attached to the hospital, who raised the alarm on a possible new Covid-19 wave in December.
2. The surge in cases at the Sungai Buloh Hospital’s ICU is due to it being a full Covid-19 hospital and a reference hospital for the Klang Valley.

The ICU also receives Covid-19 cases from other hospitals to make more ICU beds available in those hospitals for non-Covid cases.
3. The state department also reported that 92% of non-critical beds for Covid-19 patients were in use at public hospitals across Selangor.

The number of ICU beds and repurposed ICUs in the state, including Covid-19 and non-Covid-19 patients, stands at 203 beds or 80%.
Read 5 tweets
18 Nov
1. Johor’s Forest City has been ranked second out of 5 Most Useless Megaprojects in the World, according to YouTube channel Top Luxury.

“Forest City was probably too ambitious to begin with, too futuristic to truly achieve and too politically challenged to succeed anytime soon.”
2. The video, which garnered at least 5.6 million views in just four days, claims that despite the billions of dollars invested, Malaysians are unable to purchase properties in the Forest City as the prices cater to China’s market.
3. The video also claims that the project is being funded mainly through China.

“Wealthy Chinese investors who couldn’t afford the soaring prices of apartments in their own country rushed to Forest City.

“By 2019, 80% of the property owners were Chinese.”
Read 7 tweets
17 Nov
1. Pfizer will allow generic manufacturers to supply its experimental antiviral Covid-19 pill, Paxlovid, to 95 low- and middle-income countries.

Under a deal with the Medicines Patent Pool, Pfizer will not receive royalties from the manufacturers, making the treatment cheaper.
2. Pfizer will waive royalties as long as Covid-19 remains classified as a public health emergency of international concern by the WHO.

The licensing agreement is subject to the Paxlovid treatment passing ongoing trials and regulatory approval.
3. On Tuesday, Pfizer applied to the US Food and Drug Administration to grant an emergency use authorization for the Covid pill.

A Pfizer spokesperson said the company requested authorization of the treatment only for unvaccinated people at this time.
Read 5 tweets
17 Nov
1. PKR’s Ginie Lim has criticised Azmin Ali for claiming that she had been dropped as a candidate in the Melaka state election for being aligned with him.

“Walaupun saya tidak bertanding dalam Pilihan Raya Negeri Melaka kali ini, saya tetap komited dengan agenda perjuangan PH.”
2. “Kesetiaan seorang aktivis Reformis adalah pada prinsip perjuangan parti, bukan kepada individu.

“Saya menolak dengan tegas tindakan Langkah Sheraton kerana bersekongkol dengan kuasa kleptokrat dan perasuah yang telahpun ditolak oleh rakyat dalam Pilihan Raya Umum,” she said.
3. “Meskipun Azmin pernah menjadi Timbalan Presiden KEADILAN, namun amat menyedihkan bagi seorang yang kononnya memperjuangkan politik pelbagai kaum dan melawan rasuah lebih 20 tahun tetapi akhirnya terpaksa tunduk kepada acuan parti perkauman dan perasuah,” Ginie said.
Read 5 tweets
17 Nov
1. The Drug Control Authority has given conditional approval for the use of Sinovac and AstraZeneca Covid-19 vaccines as booster shots.

This would allow the doses to be administered to those aged 18 and above who received “primary series” vaccines of the same type (homologous).
2. The booster shot for the AstraZeneca vaccine will be administered six months from when the second dose was given.

For Sinovac’s CoronaVac, the booster dose will be administered three to six months after the second dose.
3. Health DG Dr Noor Hisham said the dispensing of the booster doses for both vaccines is for certain target groups determined by the Covid-19 Immunisation Task Force-Booster.

He added that the administration of the booster shots would be announced periodically.
Read 4 tweets
17 Nov
1. The Health Ministry welcomes any proposal for clinical trials on the use of marijuana for medical purposes.

Minister Khairy Jamaluddin said any parties with adequate scientific evidence for such purposes can register with the Drug Control Authority for evaluation.
2. Khairy also said the DCA had registered a cannabis-based product named Sativex in 2014, but its manufacturer requested for the registration to be cancelled in 2017.

The NPRA told Code Blue, Sativex was taken off the Malaysian market in 2017 as it was not commercially viable.
3. According to the National Pharmaceutical Regulatory Agency, Sativex was used for treatment in patients with moderate to severe spasticity due to multiple sclerosis, who have not responded adequately to other anti-spasticity medication.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!